m.

The University at Buffalo Clinical and Translational Science Institute and the Vanderbilt Institute for Clinical and Translational Research have established an NCATS-funded partnership to better understand collaboration among early-career scholars and to evaluate the impact of week-long Innovation Labs.

We will offer early-stage researchers across the Clinical and Translational Science Award consortium the opportunity to apply to participate in five-day residential Innovation Labs focused on grand challenges in clinical and translational research. 

The Innovation Labs, which will be held in Buffalo in November 2017 and in Northern Virginia in April 2018, are designed to facilitate the formation of transdisciplinary collaborative proposals, with real-time iterative feedback from a panel of mentors and reviewers. 

 

Applicants who are not selected for the Innovation Lab will still contribute to our understanding of collaboration among early-career scholars.

This work has the potential to advance the field by taking a strong translational science approach to identify and test collaboration best practices. 

Timothy Murphy, MD

Senior Associate Dean for Clinical and Translational Research
Director, Clinical and Translational Science Institute
University at Buffalo

Katherine Hartmann, MD, PhD

Associate Dean for Clinical and Translational Scientist Development
Director of Education, Training and Career Development for Vanderbilt Institute for Clinical and Translational Research
Vanderbilt University

Larry Hawk, Jr., PhD

Professor, Department of Psychology
College of Arts and Sciences
University at Buffalo

 

Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health

Research reported here was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001412 to the University at Buffalo. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.